Israeli Biotech Gets $30M Backing for its Immune Modulators for Severe Infections
Atox Bio develops immune modulators to save patients with severe infections. An oversubscribed Series F financing…
04/12/2017 - 2 minutes
Arix Bioscience
UPDATE: British Biotech Investment Company goes Public with €117M
UPDATE (17/02/2017): Arix Bioscience announced that it has successfully raised £100M (€117) in an oversubscribed IPO on…
17/02/2017 - 2 minutes
